Dextran sulfate sodium salt (MW 16000-24000)
CAS No. 9011-18-1
Dextran sulfate sodium salt (MW 16000-24000) ( —— )
Catalog No. M22832 CAS No. 9011-18-1
Dextran sulfate sodium salt (MW 16000-24000) is an anhydrous glucose polymer with a molecular weight range of 16000-24000. The sodium salt inhibits the replication of the human immunodeficiency virus by preventing the virus from absorbing the host cells.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
Size | Price / USD | Stock | Quantity |
500MG | 35 | In Stock |
|
1G | Get Quote | In Stock |
|
Biological Information
-
Product NameDextran sulfate sodium salt (MW 16000-24000)
-
NoteResearch use only, not for human use.
-
Brief DescriptionDextran sulfate sodium salt (MW 16000-24000) is an anhydrous glucose polymer with a molecular weight range of 16000-24000. The sodium salt inhibits the replication of the human immunodeficiency virus by preventing the virus from absorbing the host cells.
-
DescriptionDextran sulfate sodium salt (MW 16000-24000) is an anhydrous glucose polymer with a molecular weight range of 16000-24000. The sodium salt inhibits the replication of the human immunodeficiency virus by preventing the virus from absorbing the host cells.
-
Synonyms——
-
PathwayMicrobiology/Virology
-
TargetHIV
-
RecptorHIV;Apoptosis
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number9011-18-1
-
Formula Weight16000-24000
-
Molecular Formula——
-
Purity>98% (HPLC)
-
SolubilityNA
-
SMILES——
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Baba M, et al. Mechanism of inhibitory effect of dextran sulfate and heparin on replication of human immunodeficiency virus in vitro. Proc Natl Acad Sci U S A. 1988 Aug;85(16):6132-6.
molnova catalog
related products
-
GSK-8999
GSK-8999 (GSK-2578999) is a novel, potent HIV-1 maturation inhibitor.
-
Cyclotriazadisulfona...
Cyclotriazadisulfonamide hydrochloride is a selective inhibitor of CD4-targeted HIV entry and inhibits the co-translational translocation of human CD4 into the ER lumen in a signal peptide-dependent way.
-
NBD-14189
NBD-14189 (NBD14189) is a novel potent HIV-1 entry antagonist with potency as low as 63nM against some clinical isolates.